Mendelian randomization: a novel approach for the prediction of adverse drug events and drugrepurposing opportunities
V. M. Walker, G. Davey Smith, N. M. Davies, R. M. Martin
This paper proposes using Mendelian randomization to predict adverse drug events and drug repurposing opportunities, aiming to improve causal inference and prevent harmful drug exposures.
bioRxiv · Feb 2, 2017Pharmacology & Toxicology